44 results
424B5
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Prospectus supplement for primary offering
4:59pm
coronavirus, or together with its variants, the COVID-19 pandemic, including political or social movements arising in relation to the COVID-19 pandemic on our
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
2 Nov 23
Results of Operations and Financial Condition
4:06pm
and uncertainties, which include, without limitation, risks and uncertainties associated with Mirum’s business in general, the impact of the COVID-19 pandemic
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
13 Oct 23
Other Events
4:16pm
, including recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures, the COVID-19 pandemic and military … , the ongoing conflicts between Ukraine and Russia and Israel and Gaza, the COVID-19 pandemic, actions taken to slow its spread, actual and anticipated changes
8-K
EX-2.1
biso t9ivraak8qume5
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
ogfgkiu7yd m58d0kffs
12 Apr 23
Mirum Pharmaceuticals Announces Preliminary Unaudited First Quarter 2023 Financial Results
6:54am
8-K
EX-99.1
fmxqbfjqikastja7tyr
9 Nov 22
Results of Operations and Financial Condition
7:30am
S-3ASR
6jne13pm8be
9 Sep 22
Automatic shelf registration
4:31pm
424B5
vbw5oy9pl1szrn
10 Aug 22
Prospectus supplement for primary offering
5:07pm
8-K
pdd0rmdy0 5pm4db
10 Aug 22
Other Events
12:00am
424B5
m5rf6ci81dm
9 Aug 22
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
3j15ou2dpa yv3qpms0
4 Aug 22
Results of Operations and Financial Condition
4:03pm
8-K
EX-99.1
xxj2i5 b86
6 Jun 22
Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors
8:32am
8-K
EX-99.1
kpo3ad
5 May 22
Results of Operations and Financial Condition
8:05am